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Abstract
A monoclonal antibody designated MBR 39 has been generated against a membrane associated protein found selectively
on lysosomes. MBR 39 reacts with the cytosolic face of the lysosome and was used to develop an organelle binding assay
which reacted with high density organelles characteristic of lysosomes. These organelles contained lysosomal enzyme
markers which included the integral membrane protein acetyl-CoA:a-glucosaminide N-acetyltransferase and the soluble
 .lysosomal enzyme markers acid phosphatase mature form , b-hexosaminidase, arylsulfatase, and a-L-iduronidase. Under
conditions which disrupt lysosomes the release of the latter soluble lysosomal enzymes was demonstrated from MBR 39
bound organelles. Immunoblots of MBR 39 with purified fibroblast lysosomal membrane, demonstrated reactivity with
 .  .polypeptides of molecular mass 63 kDa major species and 73 kDa minor species . q 1997 Elsevier Science B.V.
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1. Introduction
The molecular composition of the vacuolar net-
work, which includes the endoplasmic reticulum,
Golgi, endosomes, carrier vesicles and lysosomes,
and the control of protein targeting in these or-
ganelles, have yet to be fully defined. However, some
aspects of the biogenesis of lysosomes and the intra-
cellular transport of constituent lysosomal proteins
w xhave already been described 1–5 . In general, newly
synthesized secretory, plasma membrane, lysosomal
membrane and soluble lysosomal proteins follow a
common pathway of synthesis in the rough endoplas-
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mic reticulum and transport to the trans-Golgi net-
w xwork 6 . Selective lysosomal transport is mediated
w xthrough mannose-6-phosphate receptors 4,7 , al-
though other mechanisms of lysosomal targeting ex-
ist, suggesting further complexity in this transport
process, particularly for integral membrane proteins
w x3,4,8 .
The identification of human integral lysosomal
membrane proteins or lysosomal associated mem-
 . w xbrane proteins LAMPs have been reported 9–12 ,
w xand include hLAMP-1 and hLAMP-2 13–15 . The
major proportion of both hLAMP-1 and hLAMP-2
molecules reside on the lumenal side of the lysoso-
mal membrane, and may function to protect the
w xlysosomal membrane against degradation 16 . The
pathway of intracellular traffic of hLAMP-1 and
0005-2736r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
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hLAMP-2 molecules to the lysosome is similar to
that for many soluble lysosomal hydrolases which
interact with the mannose-6-phosphate receptor, but
targeting is mediated by specific cytoplasmic tail
sequences. Other integral or membrane bound en-
zyme markers such as b-glucocerebrosidase and
acetyl-CoA:a-glucosaminide N-acetyltransferase
 .N-acetyltransferase have been described, however
like hLAMP-1 and h-LAMP-2, show a cellular distri-
w xbution which is not restricted to the lysosome 2,3,17 .
Some lysosomal proteins show a more restricted
organelle distribution, frequently showing either no
detectable expression on the cell surface or in endo-
w xsomal membranes 4 . The pathways for the intra-
cellular transport of lysosomal membrane proteins
require further definition, particularly with regard to
the added complication that lysosomes and related
acidic organelles appear to be heterogeneous in func-
w xtion 18,19 . To address these problems, lysosomal
organelles have been partially purified by density
sedimentation to allow separation from mitochondria,
peroxisomes and plasma membrane. However, the
diversity of acidic and other membrane bound or-
ganelles has made it difficult to obtain pure prepara-
tions. To resolve the question of contaminating or-
ganelles in purified preparations, markers have been
sought which assess organelle purity and some have
w xbeen partially characterized 4 .
In this paper a membrane associated protein is
described which appears to show a restricted distribu-
tion on lysosomal organelles. A monoclonal antibody
to this protein appears to react with the cytosolic side
of the lysosome and has been utilized to purify
lysosomal organelles on an analytical scale, from
subcellular organelle preparations.
2. Materials and methods
The monoclonal antibody MBR 39 and the poly-
 .clonal antibody against human LAMP-1 hLAMP-1
w xwere generated as previously described 20,21 . For
MBR 39, placenta was used as an antigen source as
this allowed the purification of preparative quantities
of lysosomal membrane. The lysosomal membrane
used for immunization was from Percoll-enriched
lysosomal organelles, which were lysed and salt
washed to remove soluble proteins and weakly asso-
w x ciated membrane proteins 20 . MBR 39 IgM sub-
.class antibody was produced as a culture supernatant
from the hybridoma cell line. The monoclonal anti-
 .body 4-S 4.1 also designated ASB 4.1 was pro-
w xduced and characterized as previously described 22 .
Sheep anti-mouse immunoglobulin antibodies per-
.oxidase-labelled, un-conjugated, or FITC-labelled
were purchased from Silenus Laboratories, Mel-
 . bourne, Australia. Digitonin saponin , Percoll col-
.loidal polyvinylpyrolidone coated silica was from
Sigma, St. Louis, MO, USA. Colloidal Indian ink
 .was Pelican drawing ink A 17 Black from Pelican
AG, Hannover, Germany.
2.1. Fibroblast culture and har˝esting
Human diploid fibroblasts were cultured as previ-
w xously described 20 , and were used to characterize
the intracellular distribution of the antigen detected
by MBR 39. For organelle fractionation experiments
fibroblasts were harvested by removing the cell cul-
ture medium, washing the cell layer twice with phos-
 .phate-buffered saline PBS before detaching the cells
by trypsin digestion and vigorous agitation as previ-
w xously described 23 . 5 ml of PBS containing 1%
 .vrv fetal calf-serum was used to suspend the cells
which were then centrifuged at 200=g for 10 min
and washed twice by resuspension in 0.25 M sucrose.
Cells from ten to fifteen 75 cm2 flasks were sus-
pended in 2.5 ml of 0.25 M sucrose, disrupted by
 . w xrepeated 10–20-times hypobaric shock 24 , and the
homogenate centrifuged at 200=g for 10 min at 48C
to remove cellular debris and unbroken cells. The
post-nuclear supernatant was centrifuged at 6000=g
for 15 min at 48C and the pellet resuspended in 0.25
 .M sucrose, 10 mM Hepes buffer pH 7.0 for frac-
tionation.
2.2. Fibroblast organelle fractionation
Granular fractions were subfractionated on self
generating Percoll gradients in 0.25 M sucrose, 10
 .mM Hepes buffer pH 7.0 . Gradients were cen-
w xtrifuged and fractionated as previously described 25 .
Fractions were isolated from the top of the gradient,
 . then either washed in 0.25 M sucrose pH 7.0 by
.centrifugation at 6000=g for 15 min at 48C , for
binding assays, or washed then freeze-thawed six
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times to disrupt the organelles for lysosomal enzyme
analysis.
2.3. Organelle immunobinding assay
Fibroblast organelles from granular fractionations
w xwere bound to MBR 39 as previously described 20 .
Briefly, sheep anti-mouse Ig antibody was bound to a
polyvinyl chloride plate and used to capture MBR 39
monoclonal antibody from culture supernatant ap-
.proximately 10 mgrml Ig . Separate subcellular frac-
tions from Percoll fractionated fibroblast organelles
  ..in 0.25 M sucrose, 10 mM Hepes buffer pH 7.0 ,
were then incubated on individual wells coated with
monoclonal antibody for 2–4 h at 208C. Unbound
organelles were removed by aspiration and each well
washed three times with 200 ml of 0.25 M sucrose,
 .10 mM Hepes buffer pH 7.0 . Wells were then
assayed for lysosomal enzyme activities or used for
antibody analysis.
2.4. Lysosomal enzyme acti˝ities
Acid phosphatase activities were determined using
w x4-methylumbelliferyl phosphate 26 . b-Hexosa-
 .minidase b-N-acetylglucosaminidase activity was
determined by the method of Leaback and Walker
w x27 . a-L-Iduronidase activity was determined using
w xmethylumbelliferyl a-L-iduronide 28 and arylsulfa-
w xtase activity using 4-methylumbelliferyl sulfate 22 .
 .N-Acetylgalactosamine-4-sulfatase 4-sulfatase ac-
tivity was determined by the method of Brooks et al.
w x29 . N-Acetyltransferase activity was determined by
w xthe method of Hopwood and Elliott 30 . Glucose-6-
phosphatase and alkaline phosphatase activities were
w xdetermined as previously described 31,32 .
2.5. Western blotting
w xPurified lysosomal membrane from placenta 20 ,
was resuspended in electrophoresis sample buffer
  .  .0.02 M Tris-HCl buffer pH 7.0 , 5% vrv mer-
 .  . .captoethanol, 1% wrv SDS, 10% vrv glycerol
and 50–100 mg of membrane protein in 100 ml of
.sample buffer electrophoresed and immunoblotted as
w xpreviously described 33 .
2.6. Immunofluorescence
Fibroblasts cultured in microscope slide chambers
were washed twice with 1 ml of PBS per chamber,
the wash buffer removed and cells fixed in 0.5 ml of
 .2% vrv formaldehyde in PBS, after 10 min at 208C
the slide chambers were emptied and chambers
washed with 1 ml of methanol and followed by two
 .separate incubations with 1 ml of 10% vrv fetal
calf serum in PBS for 15 min. Each chamber was
incubated with monoclonal antibody culture super-
 .  .natant 1 ml containing 0.15% wrv digitonin
 .saponin for 2 h at 208C. The culture supernatant
was aspirated and each chamber subjected to three 5
 .min washes with 1 ml of PBS containing 10% vrv
fetal calf serum. Each chamber was incubated with
0.5 ml of a 1:15 dilution of FITC-conjugated sheep
 .anti-mouse Ig antibody in PBS containing 10% vrv
fetal calf serum for 1 h at 208C, and following three
washes with 1 ml of PBS each, the chamber mount
 .was removed from the slides and 20 ml of 50%
 .vrv glycerol in PBS added to the slide before
addition of a coverslip. Cells were inspected by
epifluorescence microscopy.
3. Results
3.1. Preliminary characterization of MBR 39
In preliminary experiments a monoclonal antibody
designated MBR 39 was shown to react by ELISA
with lysosomal membrane and in an organelle bind-
ing assay reacted with vesicles which contained b-
hexosaminidase, acid phosphatase and arylsulfatase
w xenzyme activities 20 .
3.2. Immunofluorescence
To visualize the intracellular distribution of the
MBR 39 antigen, human fibroblasts were reacted
with the monoclonal antibody MBR 39 and an
FITC-labeled second antibody. Non-permeabilized
cells were not reactive with MBR 39 demonstrating
little or no detectable cell surface antigen expression.
However, saponin-treated cells revealed immunofluo-
rescent organelles with a characteristic perinuclear
 .distribution Fig. 1A . MBR 39 appeared to consis-
( )D.A. Brooks et al.rBiochimica et Biophysica Acta 1327 1997 162–170 165
tently react with at most a subset of the organelles
detected by a polyclonal antibody against hLAMP-1,
when tested on different samples of the same fibrob-
last cell lines see representative example Fig. 1A for
.MBR 39 and Fig. 1B for hLAMP-1 .
3.3. Interaction of organelles with MBR 39
The lysosomal nature of the organelles bound by
the MBR 39 monoclonal antibody was substantiated
in an organelle immunobinding assay using fibroblast
post-nuclear supernatant, granular fraction and lysed
 .granular fraction Fig. 2 . MBR 39 bound organelles
contained acid phosphatase, b-hexosaminidase, a-L-
iduronidase and arylsulfatase activities, from post-
nuclear supernatant and from granular fraction but
not from either freeze-thawed granules i.e., non-in-
.tact organelles , or from post-nuclear supernatant
which had been centrifuged to remove the organelle
 .fraction Fig. 2a and Fig. 2b . Thus MBR 39 only
interacted with soluble lysosomal enzymes where
they were contained within intact organelles. Soluble
Fig. 1. The intracellular distribution of the MBR 39 protein as shown by immunofluorescence. In saponin-treated fibroblasts, MBR 39
 .reacted with organelles which showed a perinuclear distribution Fig. 1A . No reactivity was observed on the cell surface either with or
 .without saponin treatment data not shown for without saponin treatment . MBR 39 only appeared to react with a subset of the organelles
detected by a polyclonal anti-hLAMP-1 antibody, when tested on different samples of the same cell line Fig. 1A for MBR 39 reactivity
.and Fig. 1B for hLAMP-1 reactivity . Fibroblasts stained with FITC-labeled second antibody only, showed little or no background
 .reactivity data not shown .
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lysosomal enzyme activities could be released from
the MBR 39 bound vesicles by freeze-thawing the
 .organelles after attachment to the antibody Fig. 3 .
The amount of lysosomal enzyme activities bound by
MBR 39 were enriched in the granular fraction com-
pared to the post-nuclear supernatant for all enzyme
activities except acid phosphatase, suggesting that not
all of the acid phosphatase activity is bound by MBR
 .39 Fig. 2a . MBR 39 did not bind glucose-6-phos-
phatase activity, a microsomal marker, and did not
bind alkaline phosphatase, a Golgi and plasma mem-
brane marker, establishing specificity of this marker
 .for lysosomal or endosomal organelles Fig. 2 .
Fig. 2. An organelle binding assay was used to determine the
nature of MBR 39 reactive vesicles. Organelles were from fibrob-
 .last preparations of either post-nuclear supernatant PN , or post-
 .  .nuclear supernatant minus granules S , or granular fraction GF ,
 .  .or lysed granular fraction LG . Blank B represents substrate
reactivity on MBR 39 antibody controls. Bound organelles from
.100 ml of sample were assayed for either acid phosphatase
 .  .ACP , b-hexosaminidase HEX , and glucose-6-phosphatase
 .  .G6P shown in Fig. 2a, or a-L-iduronidase MUI , arylsulfatase
 .  .ARS and alkaline phosphatase ALP as shown in Fig. 2b.
Results are a mean of duplicate determinants and are expressed
as nmol miny1. The total enzyme activities in 100 ml of fibrob-
last post-nuclear supernatant were: acid phosphatase 0.28 nmol
y1.  y1.min , b-hexosaminidase 0.33 nmol min , glucose-6-phos-
 y1. phatase 0.008 nmol min , alkaline phosphatase 0.48 nmol
y1.  y1.min , arylsulfatase 0.02 nmol min and a-L-iduronidase
 y1.0.03 nmol min . The recovery of enzyme activities in MBR
39 bound organelles from the PNS starting material was up to
45%.
Fig. 3. Nature of enzyme released from MBR 39 bound or-
ganelles. Organelles from a fibroblast post-nuclear supernatant
were bound to MBR 39 antibody, as described in Section 2.
Organelles bound to MBR 39 were lysed by freeze-thawing the
96 well plate twice, and the supernatant assayed released en-
.  .zyme for either acid phosphatase ACP or b-hexosaminidase
 .HEX enzyme activity after centrifugation at 100000= g, to
remove any detached organelles or free membrane. The wells
 .containing lysed organelles MBR 39, lysed , were washed twice
 .with 0.02 M Tris-HCl containing 0.25 M NaCl and 1% wrv
ovalbumin before assaying either acid phosphatase or b-
hexosaminidase enzyme activities. Blank, represents the substrate
blank for the enzyme assayed. Enzyme activities were expressed
as nmolrmin and represent an average of duplicate results.
3.4. MBR 39 reacts with high density organelles
characteristic of lysosomes
The subcellular distribution of MBR 39 reactive
organelles was investigated using fibroblast granular
fractions which had been separated on Percoll density
 .gradients Fig. 4 . The analysis of acid phosphatase
activity on fractionated organelles demonstrated two
main peaks of enzyme activity, the first in low den-
sity organelles, characteristic of endosomes and the
second in high density organelles, characteristic of
 .lysosomes Fig. 4b . Freeze-thawed organelles
showed the same acid phosphatase enzyme activity as
intact organelles indicating no latency in the assay of
 .intact organelles Fig. 4b . When the fractions from
 .lysed organelles were centrifuged 100 000=g and
washed in buffer A to give membrane only fractions,
the acid phosphatase activity distributed almost ex-
 .clusively into the endosomal peak Fig. 4b . Thus,
the soluble or lysosomal form of acid phosphatase
could be released by organelle disruption, while un-
der the same conditions the endosomal form of acid
phosphatase remained associated with the membrane
fraction.
( )D.A. Brooks et al.rBiochimica et Biophysica Acta 1327 1997 162–170 167
The monoclonal antibody MBR 39 was used to
bind organelles from the same Percoll gradient. The
organelles binding to MBR 39 were characterized by
the detection of acid phosphatase activity and found
to be predominantly in the lysosomal peak, with only
a small amount reacting with endosomal fractions
 .Fig. 4c . That MBR 39 bound organelles were lyso-
somes, was shown by the release of free acid phos-
phatase when the organelle fractions were freeze-
 .thawed prior to binding with antibody Fig. 4c . The
lysosomal nature of these fractions was further sub-
stantiated by the coincident distribution of the lysoso-
mal enzyme markers a-L-iduronidase, N-acetyltrans-
ferase and arylsulfatase with MBR 39 bound acid
 .phosphatase Fig. 4 .
The lysosomal enzyme activities were also shown
to be contained within the organelles bound by MBR
39 by the binding experiments with unfractionated
 .organelle preparations Fig. 2 . The small amount of
MBR 39 bound acid phosphatase activity, detected in
 .low density endosomal fractions Fig. 4c , appeared
to be soluble acid phosphatase that was released upon
organelle disruption. This may indicate either a small
proportion of the MBR 39 antigen is localized in
endosomes, or that there were some lysosomes co-
fractionating with endosomes in the low density re-
gion of the gradient. The latter was supported by the
observation that acid phosphatase reactivity did not
bind to MBR 39 from this region of the gradient for
lysed organelles i.e., representing soluble lysosomal
acid phosphatase, not the membrane bound endoso-
.mal form; Fig. 4c .
3.5. MBR 39 reacts with the cytosolic side of the
lysosome
Without sequence information it is difficult to
definitively identify the MBR 39 bound protein as an
integral membrane protein. We have however at-
tempted to determine whether the epitope detected by
MBR 39 is on the cytosolic or the lumenal side of the
Fig. 4. MBR 39 primarily detects high density organelles charac-
teristic of lysosomes. To establish the lysosomal reactivity of
MBR 39, fibroblast granular fractions were subfractionated on
Percoll density gradients and the purified organelles analysed for
MBR 39 interaction and for the co-distribution of lysosomal
 .markers. The lysosomal enzymes N-acetyltransferase GNAT ,
 .  .arylsulfatase ARS and a-L-iduronidase MUI localized mainly
 .in high density organelles fractions 16–20, Fig. 4a . The or-
ganelles reacting with MBR 39 detected by acid phosphatase
 . .  .ACP activity , were also mainly in fractions 16–20 Fig. 4c
and therefore coincident with high density lysosomes. The solu-
 .ble mature form of acid phosphatase lysosomal was distinguish-
 .able from the membrane bound endosomal form of acid phos-
 .phatase Fig. 4b . MBR 39 did not bind acid phosphatase from
preparations of organelles which had been lysed and only reacted
with organelles containing the soluble mature form of acid
 .phosphatase Fig. 4c . Whole, represents intact organelles; lysed,
represents freeze-thawed organelles; membrane, represents lysed
organelles where membrane fractions were separated from the
soluble organelle contents. Figs. 4a and 4b, represents the direct
assay of enzyme activities on organelle fractions, while Fig. 4c
represents interaction with the monoclonal antibody MBR 39. All
enzyme activities were expressed in nmolrmin=200.
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Fig. 5. MBR 39 reacts with the cytosolic side of the lysosome.
Fibroblast granular fractions were subfractionated on a Percoll
density gradient and the organelle fractions either assayed for
 .acid phosphatase activity ‘: Fig. 5a , and b-hexosaminidase
 .activity v: Fig. 5a or reacted in an organelle binding assay
 .  .with either anti-hLAMP-1 I: Fig. 5b or MBR 39 B: Fig. 5b
monoclonal antibodies. Acid phosphatase activity localized into
both a high density peak and a low density peak, while b-
hexosaminidase localized selectively in the high density or-
ganelles characteristic of lysosomes. Antibody to hLAMP-1 failed
to bind organelles containing acid phosphatase. In contrast MBR
39 bound high density organelles as measured by their acid
phosphatase content. The latter organelles were coincident with
those organelles containing b-hexosaminidase enzyme activity.
lysosomal membrane. Organelles from a fibroblast
granular fraction separated on Percoll gradients, were
incubated with either MBR 39 or a polyclonal anti-
hLAMP-1 antibody. Fractions containing high den-
sity organelles with soluble acid phosphatase activity
were bound to MBR 39 but did not interact with
 .hLAMP-1 antibodies Fig. 5 . As the hLAMP-1 anti-
body has been shown to react with the lumenal side
of the lysosome, it is suggested that the MBR 39
epitope is on the opposite or cytosolic side of the
lysosome. The failure of hLAMP-1 to bind high
density lysosomal organelles, which have been shown
to contain soluble acid phosphatase, indicates that the
organelles from this region of the Percoll gradient are
intact and in the correct orientation rather than dis-
rupted and reformed in the reverse orientation, which
would expose the hLAMP-1 reactive domain that has
been shown to be on the lumenal side of the lyso-
.some .
3.6. Immunochemical characterization of the
polypeptide detected by MBR 39
Salt washed placental lysosomal membrane frac-
w xtions 20 , were solubilized in reducing sample buffer
 .containing 1% wrv SDS , electrophoresed and
Western blotted using MBR 39 monoclonal antibody
 .Fig. 6 . Two polypeptide species of molecular mass
 . 63 kDa major polypeptide and 73 kDa minor
.polypeptide were identified by MBR 39 reactivity.
The polypeptides identified showed only very weak
cross reactivity with an IgM monoclonal antibody
Fig. 6. Immunochemical characterization of the MBR 39 reactive
protein. Purified placental lysosomal membranes prepared as
w x.previously described in Brooks et al., 1993 20 were washed in
  ..1 M KCI and 0.25 M NaCl in 0.02 M Tris buffer pH 7.0 and
immunoblotted using MBR 39 monoclonal antibody and a perox-
idase labelled sheep anti-mouse Ig antibody. The molecular mass
markers were as indicated on the left of the figure and are in
 .kilodaltons kDa . The results indicate that the MBR 39 reactive
protein is membrane associated and is detected as two poly-
 .  .peptides of molecular mass, 63 kDa major and 73 kDa minor .
In a negative control immunoblot, another monoclonal antibody
of the same IgM subclass which reacts with another lysosomal
.membrane protein had only very weak cross reactivity with
 .these and other polypeptides data not shown .
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 .same subclass as MBR 39 which reacted with an-
 .other lysosomal membrane protein not shown . As
the MBR 39 reactive protein was not extracted from
lysosomal membrane fractions by either 1 M KC1 or
0.25 M NaCl washes, but was solubilized in 1%
SDS, this protein appears to be either tightly associ-
ated with the lysosomal membrane or possibly an
integral membrane protein.
4. Discussion
A monoclonal antibody, MBR 39 was generated
against purified preparations of placental lysosomal
membrane and has been shown to react with a mem-
brane associated protein on the cytosolic side of the
lysosome. The MBR 39 reactive protein was not
readily extractable by high ionic strength solubility
but was detergent extractable indicating that it was
either tightly associated with the lysosomal mem-
brane or an integral lysosomal membrane protein
w x20 . Western blot analysis under reducing conditions
demonstrated reactivity with two polypeptide species
 .of molecular mass, 63 kDa major and 73 kDa
 .minor . Organelle binding studies indicated that the
MBR 39 protein was located in lysosomes that con-
tained the soluble lysosomal enzymes b-hexosa-
minidase, a-L-iduronidase, arylsulfatase and acid
phosphatase. However, MBR 39 did not appear to
react with either organelles containing Golgi markers
or with the cell surface. Subcellular fractionation
indicated that MBR 39 protein was distributed pri-
marily in high density organelles which co-locate
with soluble lysosomal enzyme markers, as well as
an integral lysosomal membrane protein N-acetyl-
transferase. MBR 39 reacted with a subset of low
density organelles characteristic of endosomes, but
these organelles were shown to contain soluble acid
phosphatase, suggesting they were lower density
lysosomes. Thus, MBR 39 appears to present as a
specific marker for lysosomal organelles.
The intracellular traffic of membrane associated
molecules is crucial in the understanding of the struc-
tural and functional basis of endosomal and lysoso-
mal heterogeneity and thus, the biogenesis of the
vacuolar compartment. Endosome-associated antigens
w xhave been characterized 4,18,34–36 , giving rise to
considerable information on the individual compart-
ments involved in the transfer of internalized
molecules to lysosomes and the membrane composi-
tion and thus, structurerfunction of these specialized
organelles. The endosomal antigens reported thus far,
appear to be distinct from the protein detected by
w xMBR 39, both in molecular size 18,36 and in their
intracellular distribution. However, while MBR 39
showed predominantly lysosomal reactivity, it is
likely that the molecule traffics through the endoso-
mal compartment during its normal processing, as is
the case for other lysosomal proteins and lysosomal
membrane proteins.
The characterization of membrane proteins of the
lysosome has also revealed several proteins which
show predominantly lysosomal intracellular distribu-
w xtion 9,10,14,37 . However, the antigens identified to
date do not appear to exhibit the same biochemical
properties as the protein detected by MBR 39. The
localization of the MBR 39 protein to the cytosolic
side of the lysosome potentially provides a unique
marker for lysosomal biogenesis studies. Moreover,
the MBR 39 protein may have a key functional role
in the lysosome due to its observed specific localiza-
tion in lysosomal organelles.
The biogenesis of the lysosomal enzyme acid
 .phosphatase tartrate inhibitable form has been char-
w xacterized 38–41 . Lysosomal acid phosphatase is
initially passaged from the endoplasmic reticulum to
the trans-Golgi and to endosome vesicles in ;30
.min and at this stage has a short 19-amino-acid
cytoplasmic tail, a membrane spanning domain and a
w xhighly glycosylated ectoplasmic domain 41 . This
precursor form of the enzyme has been proposed to
rapidly recycle between the endosome pool and the
 .cell surface 5–6 h retention before processing, via
proteolytic clipping of the cytoplasmic tail and ecto-
plasmic domain, results in a soluble mature form of
lysosomal acid phosphatase which is delivered to the
w xlumen of the lysosome 41 . Percoll fractionation
studies reported in this paper support the proposed
processing differences between endosomally located
membrane bound form and lysosomally located solu-
ble form of acid phosphatase.
w xPeters et al. 41 concluded that endosome cell
surface recycling may be an obligatory passage for
the processingrmaturation of many lysosomal en-
zymes. In our membrane binding studies and by
immunofluorescence analysis we could demonstrate
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little or no cell surface reactivity with MBR 39.
Moreover, we concluded that at most, only minimal
amounts of the MBR 39 protein resides in the endo-
some pool and that it is mainly localized in lysosomal
organelles.
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